Predicting the Response to EGFR Tyrosine Kinase Inhibitor Gefitinib in Head-and-Neck Cancer -- The Carissa GORTEC 2004-02 Study

J. Thariat; R. Bensadoun; M. Etienne-Grimaldi; D. Grall; F. Penault-Llorca; O. Dassonville; A. Cayre; P. Giraud; E. Van Obberghen-Schilling; G. Milano

doi:10.1016/j.ijrobp.2012.07.059

Predicting the Response to EGFR Tyrosine Kinase Inhibitor Gefitinib in Head-and-Neck Cancer -- The Carissa GORTEC 2004-02 Study

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2012.07.059 ◽

2012 ◽

Vol 84 (3) ◽

pp. S21 ◽

Cited By ~ 1

Author(s):

J. Thariat ◽

R. Bensadoun ◽

M. Etienne-Grimaldi ◽

D. Grall ◽

F. Penault-Llorca ◽

...

Keyword(s):

Head And Neck Cancer ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Head And Neck ◽

Neck Cancer ◽

Kinase Inhibitor ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase

Download Full-text

PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells

Oncogene ◽

10.1038/onc.2009.108 ◽

2009 ◽

Vol 28 (24) ◽

pp. 2348-2357 ◽

Cited By ~ 42

Author(s):

Q Sun ◽

L Ming ◽

S M Thomas ◽

Y Wang ◽

Z G Chen ◽

...

Keyword(s):

Head And Neck Cancer ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Head And Neck ◽

Cancer Cells ◽

Neck Cancer ◽

Kinase Inhibitor ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase ◽

Induced Apoptosis

Download Full-text

Dose scheduling of the dual VEGFR and EGFR tyrosine kinase inhibitor vandetanib (ZD6474, Zactima®) in combination with radiotherapy in EGFR-positive and EGFR-null human head and neck tumor xenografts

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-007-0460-5 ◽

2007 ◽

Vol 61 (2) ◽

pp. 179-188 ◽

Cited By ~ 34

Author(s):

Daniel L. Gustafson ◽

Barbara Frederick ◽

Andrea L. Merz ◽

David Raben

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Head And Neck ◽

Kinase Inhibitor ◽

Human Head ◽

Head And Neck Tumor ◽

Egfr Tyrosine Kinase Inhibitor ◽

Tumor Xenografts ◽

Neck Tumor ◽

Egfr Tyrosine Kinase

Download Full-text

Synergistic inhibition of head and neck tumor growth by green tea (−)‐epigallocatechin‐3‐gallate and EGFR tyrosine kinase inhibitor

International Journal of Cancer ◽

10.1002/ijc.23585 ◽

2008 ◽

Vol 123 (5) ◽

pp. 1005-1014 ◽

Cited By ~ 68

Author(s):

Xin Zhang ◽

Hongzheng Zhang ◽

Mourad Tighiouart ◽

John E. Lee ◽

Hyung J. Shin ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tumor Growth ◽

Tyrosine Kinase Inhibitor ◽

Head And Neck ◽

Green Tea ◽

Kinase Inhibitor ◽

Head And Neck Tumor ◽

Egfr Tyrosine Kinase Inhibitor ◽

Synergistic Inhibition ◽

Egfr Tyrosine Kinase

Download Full-text

Sequence dependence of cell growth inhibition by EGFR-tyrosine kinase inhibitor ZD1839, docetaxel, and cisplatin in head and neck cancer

Head & Neck ◽

10.1002/hed.21103 ◽

2009 ◽

Vol 31 (10) ◽

pp. 1263-1273 ◽

Cited By ~ 2

Author(s):

Carmen M. Klass ◽

Mi Sun Choe ◽

Selwyn J. Hurwitz ◽

Mourad Tighiouart ◽

Xin Zhang ◽

...

Keyword(s):

Head And Neck Cancer ◽

Cell Growth ◽

Tyrosine Kinase ◽

Growth Inhibition ◽

Tyrosine Kinase Inhibitor ◽

Head And Neck ◽

Kinase Inhibitor ◽

Cell Growth Inhibition ◽

Egfr Tyrosine Kinase Inhibitor ◽

Sequence Dependence

Download Full-text

Dual-agent molecular targeting of growth factor receptors in hepatocellular cancer: Combining anti-EGFR antibody with an EGFR tyrosine kinase inhibitor

Zeitschrift für Gastroenterologie ◽

10.1055/s-2005-920152 ◽

2005 ◽

Vol 43 (05) ◽

Author(s):

A Hüther ◽

M Höpfner ◽

D Schuppan ◽

H Scherübl

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Hepatocellular Cancer ◽

Growth Factor Receptors ◽

Molecular Targeting ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase ◽

Egfr Antibody

Download Full-text

Anlotinib Hydrochloride Combined With EGFR-Tyrosine Kinase Inhibitor (TKI) in Treating Advanced NSCLC Patients With Acquired Resistance to EGFR-TKI

Case Medical Research ◽

10.31525/ct1-nct04007835 ◽

2019 ◽

Author(s):

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Advanced Nsclc ◽

Kinase Inhibitor ◽

Acquired Resistance ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase ◽

Nsclc Patients ◽

Egfr Tki

Download Full-text

O-247 Molecular mechanisms of sensitivity and resistance to the HER1/EGFR-tyrosine kinase inhibitor erlotinib (Tarceva™)

Lung Cancer ◽

10.1016/s0169-5002(03)91905-2 ◽

2003 ◽

Vol 41 ◽

pp. S72 ◽

Cited By ~ 6

Author(s):

Roman Perez-Soler ◽

Qun Dai ◽

Yi-He Ling ◽

Marie Lee ◽

Glenn Kroog ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Molecular Mechanisms ◽

Kinase Inhibitor ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase

Download Full-text

Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib—A Phase II Trial

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-11-0048 ◽

2011 ◽

Vol 10 (6) ◽

pp. 1102-1112 ◽

Cited By ~ 113

Author(s):

Monika E. Hegi ◽

Annie-Claire Diserens ◽

Pierre Bady ◽

Yuta Kamoshima ◽

Mathilde C. M. Kouwenhoven ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Phase Ii ◽

Pathway Analysis ◽

Kinase Inhibitor ◽

Phase Ii Trial ◽

Preoperative Treatment ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase

Download Full-text

P3.01-073 TPX-0005 with an EGFR Tyrosine Kinase Inhibitor (TKI) Overcomes Innate Resistance in EGFR Mutant NSCLC

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2017.09.1514 ◽

2017 ◽

Vol 12 (11) ◽

pp. S2230

Author(s):

R. Rosell ◽

N. Karachaliou ◽

J.J. Cui ◽

I. Chaib ◽

J. Berenguer ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Egfr Tyrosine Kinase Inhibitor ◽

Innate Resistance ◽

Egfr Tyrosine Kinase ◽

Egfr Mutant

Download Full-text

EGFR Tyrosine Kinase Inhibitor Monotherapy Should Remain the Standard First-Line Treatment in Advanced EGFR-Mutant NSCLC

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.08.015 ◽

2021 ◽

Vol 16 (11) ◽

pp. 1793-1797

Author(s):

Sophie Stock-Martineau ◽

Frances A. Shepherd

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Line Treatment ◽

First Line ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase ◽

Egfr Mutant ◽

First Line Treatment

Download Full-text